Dr. Inrig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 The City Dr S
Orange, CA 92868Phone+1 714-880-7812
Education & Training
- Duke UniversityMHS, Clinical Research, 2004 - 2006
- Duke University HospitalFellowship, Nephrology, 2003 - 2005
- Duke University HospitalResidency, Internal Medicine, 2000 - 2003
- Loma Linda University School of MedicineClass of 2000
- California State University, SacramentoB.A., Biochemistry, Magna Cum Laude, 1992 - 1996
Certifications & Licensure
- CA State Medical License 2014 - 2026
- TX State Medical License 2008 - 2016
- NC State Medical License 2000 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Who's Who in America Marquis, 2008
- R. Snyderman Clinical Research Fellowship Grant Award R. Snyderman Clinical Research Fellowship Grant, 2006
- Join now to see all
Clinical Trials
- Erythropoietin Resistance in Anemia of Chronic Kidney Disease Start of enrollment: 2007 Aug 01
- How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis Start of enrollment: 2007 Sep 01
- Mechanisms and Treatment of Intradialytic Hypertension Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 633 citationsKDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 UpdateMichael Rocco, John T. Daugirdas, Thomas A. Depner, Jula K. Inrig, Rajnish Mehrotra
American Journal of Kidney Diseases. 2015-11-01 - 35 citationsEfficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.Brad H Rovin, Jonathan Barratt, Hiddo J L Heerspink, Charles E Alpers, Stewart Bieler
Lancet. 2023-12-02 - 421 citationsSecondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomesLynda A. Szczech, Huiman X. Barnhart, Jula K. Inrig, Donal N. Reddan, Shelly Sapp
Kidney International. 2008-09-02
Journal Articles
- Intradialytic blood pressure variability is associated with increased all-cause and cardiovascular mortalityFlythe JE, Inrig JK, Shafi T, Chang TI, Cape K, Dinesh K, Kunaparaju S, Brunelli SM, Am J Kidney Dis, 3/6/2013
- Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.McCullough PA, Barnhart HX, Inrig JK, Reddan D, Sapp S, Califf RM, Patel UD, Singh AK, Szczech LA, Am J Nephrol, 1/1/2013
- Practice Pointers: Hypertension and blood pressure goals in the dialysis unit.Inrig JK and Griffiths K, ASN Kidney News, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Desing and Rationale for a randomized, double-blind, placebo-controlled phase 2 study to evaluate efficacy and safety of nalfurafine (MT_9938) for treatment of uremic ...Yosipovich G, Inrig J, Mayo Marlyn, Block G, Takei K, Lieberman B, Palumbo JM, American Society of Nephrology Annual Meeting, San Diego, CA, 1/1/2012
- Systematic Analysis of Nephrology Studies in ClinicalTrials.gov.Inrig JK, Califf RM, Tasneem A, Chiswell K, Patel UD, American Society of Nephrology Annual Meeting, San Diego, CA, 1/1/2012
- Dialysate Sodium Promotes Endothelial Cell Dysfunction in Patients with Intradialytic Hypertension.Kim C, Van Buren P, Klimas N, Inrig JK, American Society of Nephrology Annual Meeting, San Diego, CA, 1/1/2012
- Join now to see all
Lectures
- Topic: Blood Pressure, Salt and Water in Hemodialysis Patients10/10/2013
- The Effect Of Dialysate Sodium On Intradialytic Hypertension.San Francisco, CA - 4/28/2013
- Strategies to Optimize Blood Pressure Management in Dialysis4/19/2013
- Join now to see all
Other
- Blood Pressure with EpoInrig JK, Renal and Urology News, Jody A. Charnow
11/1/2012 - "Dialysis Data Shines Light on Clinic Disparities Detailed information on North Texas dialysis clinic death rates."Inrig JK, NBC Interview with Ken Kalthoff
http://www.nbcdfw.com/news/health/Dialysis-Data-Shines-Light-on-Clinic-Disparities-147838245.html
4/17/2012 - Hot issues to watch for in 2011Inrig JK, Saggi S, Weiner D, Shaffer R, Mehrotra on behalf of the ASN Dialysis Advisory Group. Bundled Payments, ASN Kidney News
1/1/2011 - Join now to see all
Press Mentions
- The Sudden Progress in Rare Kidney Disease Is Built on Years of DedicationOctober 14th, 2024
- Travere’s FSGS Therapy Trial Fails to Meet Primary Efficacy EndpointMay 2nd, 2023
- Travere Therapeutics Announces Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental GlomerulosclerosisMay 2nd, 2023
- Join now to see all
Committees
- Inaugural Board of Directors, Kidney Health Initiative 2013 - 2017
- Member, KDOQI Hemodialysis Adequacy Clinical Practice Guidelines Update Work Group, National Kidney Foundation 2012 - 2015
Professional Memberships
- Member
- Fellow
- Member
- Council - Kidney in Cardiovascular Disease
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: